Your browser doesn't support javascript.
loading
Viral suppression and self-reported ART adherence after 3 years of universal testing and treatment in the HPTN 071 (PopART) community-randomised trial in Zambia and South Africa: a cross-sectional analysis.
Macleod, David; Shanaube, Kwame; Skalland, Timothy; Limbada, Mohammed; Mandla, Nomtha; Bwalya, Justin; Schaap, Ab; Yang, Blia; Donnell, Deborah; Piwowar-Manning, Estelle; Eshleman, Susan H; Hoddinott, Graeme; Bond, Virginia; Moore, Ayana; Griffith, Sam; Bock, Peter; Ayles, Helen; Fidler, Sarah; Hayes, Richard; Floyd, Sian.
Affiliation
  • Macleod D; International Statistics and Epidemiology Group, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK. Electronic address: david.macleod@lshtm.ac.uk.
  • Shanaube K; Zambart, School of Public Health, University of Zambia, Lusaka, Zambia.
  • Skalland T; HPTN Statistical and Data Management Centre, Seattle, WA, USA.
  • Limbada M; Zambart, School of Public Health, University of Zambia, Lusaka, Zambia.
  • Mandla N; Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Stellenbosch University, Cape Town, South Africa.
  • Bwalya J; Zambart, School of Public Health, University of Zambia, Lusaka, Zambia.
  • Schaap A; International Statistics and Epidemiology Group, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK; Zambart, School of Public Health, University of Zambia, Lusaka, Zambia.
  • Yang B; Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Stellenbosch University, Cape Town, South Africa.
  • Donnell D; HPTN Statistical and Data Management Centre, Seattle, WA, USA.
  • Piwowar-Manning E; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Eshleman SH; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Hoddinott G; Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Stellenbosch University, Cape Town, South Africa.
  • Bond V; Global Health and Development Department, Faculty of Public Health and Policy, London School of Hygiene & Tropical Medicine, London, UK; Zambart, School of Public Health, University of Zambia, Lusaka, Zambia.
  • Moore A; FHI 360, HIV Prevention Trials Network, Durham, NC, USA.
  • Griffith S; FHI 360, HIV Prevention Trials Network, Durham, NC, USA.
  • Bock P; Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Stellenbosch University, Cape Town, South Africa.
  • Ayles H; Zambart, School of Public Health, University of Zambia, Lusaka, Zambia.
  • Fidler S; Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, UK.
  • Hayes R; International Statistics and Epidemiology Group, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
  • Floyd S; International Statistics and Epidemiology Group, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
Lancet HIV ; 9(11): e751-e759, 2022 11.
Article in En | MEDLINE | ID: mdl-36332652
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Anti-HIV Agents Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Prevalence_studies Limits: Female / Humans / Male Country/Region as subject: Africa Language: En Journal: Lancet HIV Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Anti-HIV Agents Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Prevalence_studies Limits: Female / Humans / Male Country/Region as subject: Africa Language: En Journal: Lancet HIV Year: 2022 Type: Article